OMNICELL, INC. OMCL

Technology SIC 3571 - Electronic Computers Nasdaq

Omnicell, a leading healthcare technology provider focused on empowering autonomous medication management, is committed to solving the critical challenges inherent in medication management and elevating the role of clinicians within healthcare as an essential component of care delivery. Omnicell is focused on helping its customers define and deliver a cost-effective medication management strategy designed to equip and empower pharmacists and nurses to focus on patient care rather than administrative tasks, and to drive improved clinical, operational, and financial outcomes across all care settings. We are doing this with an industry-leading medication management infrastructure which includes storage and dispensing automation powered by an intelligence ecosystem. Our comprehensive set of solutions provides the critical foundation for customers to realize the Autonomous Pharmacy, an industry-wide vision defined by pharmacy leaders for improving operational efficiencies and ultimately targeting zero-error medication management alongside 5 other outcomes laid out in the Autonomous Pharmacy framework.

Last close 34.37 2026-09-04
Market cap $1.57B 2026-06-30 share count
52-week range 29.06 - 55.00

Valuation FY2025 figures against the last close

P/S1.3x
P/E859.2x
P/FCF18.0x
EV/EBITDA18.7x
Dividend yield
Diluted EPS0.04

Annual financial statements

Income statement

Fiscal year FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Revenue $1.18B$1.11B$1.15B$1.30B$1.13B$892.2M$897.0M$787.3M$712.7M$695.9M
Cost of revenue $681.4M$641.2M$650.3M$707.0M$577.4M$478.9M$460.1M$415.0M$394.1M$378.8M
Gross profit $503.4M$471.0M$496.8M$589.0M$554.7M$413.3M$436.9M$372.3M$318.6M$317.1M
R&D $88.7M$90.4M$97.1M$105.0M$75.7M$70.2M$68.6M$64.8M$66.0M$57.8M
SG&A $409.6M$380.3M$434.6M$486.3M$389.4M$307.6M$289.9M$263.1M$241.5M$237.9M
Total operating expenses $498.3M$470.7M$531.7M$591.3M$465.1M$377.8M$358.6M$327.9M$307.5M$295.7M
Operating income $5.2M$337.0K-$34.9M-$2.3M$89.5M$35.5M$78.4M$44.4M$11.1M$21.4M
Pre-tax income $11.3M$25.6M-$20.1M-$2.5M$66.0M$29.3M$73.9M$35.6M$4.5M$13.0M
Income tax $9.3M$13.1M$263.0K$8.1M$11.8M$2.8M$12.6M$2.1M$26.0M$3.2M
Net income $2.1M$12.5M-$20.4M$5.6M$77.8M$32.2M$61.3M$37.7M$30.5M$9.8M
EPS, basic 0.040.27-0.450.131.790.761.480.960.810.27
EPS, diluted 0.040.27-0.450.121.620.741.430.930.790.26
Shares, diluted (wtd. avg.) $46.4M$46.3M$45.2M$45.9M$47.9M$43.7M$42.9M$40.6M$38.7M$36.9M

Balance sheet

Fiscal year FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash and equivalents $196.5M$369.2M$468.0M$352.8M$355.6M$489.9M$127.2M$67.2M$32.4M$54.5M
Receivables $216.9M$256.4M$252.0M$299.5M$240.9M$190.1M$218.4M$196.2M$190.0M$150.3M
Inventory $100.9M$88.7M$110.1M$147.5M$119.9M$96.3M$108.0M$100.9M$96.1M$69.3M
Total current assets $680.1M$815.5M$927.6M$881.8M$780.7M$829.4M$483.2M$397.1M$352.3M$315.4M
Property, plant and equipment $120.1M$112.7M$108.6M$94.0M$71.1M$59.1M$54.2M$51.5M$42.6M$42.0M
Goodwill $737.9M$734.7M$735.8M$734.3M$738.9M$499.3M$336.5M$335.9M$337.8M$327.7M
Other intangibles $170.1M$188.3M$211.2M$242.9M$277.6M$168.2M$124.9M$143.7M$168.1M$190.3M
Total assets $1.97B$2.12B$2.23B$2.21B$2.14B$1.82B$1.24B$1.08B$1.02B$935.1M
Accounts payable $44.0M$51.8M$45.0M$63.4M$71.5M$40.3M$46.4M$38.0M$48.3M$27.1M
Short-term debt $0$15.2M$8.4M
Total current liabilities $476.6M$595.7M$367.8M$428.4M$876.2M$276.4M$237.0M$204.6M$205.2M$180.9M
Long-term debt $50.0M$135.4M$194.9M$245.7M
Total liabilities $742.9M$877.6M$1.04B$1.08B$995.8M$857.0M$395.6M$401.6M$462.0M$503.5M
Retained earnings $384.9M$382.9M$370.4M$390.7M$368.6M$290.7M$258.8M$197.5M$159.7M$100.4M
Total equity $1.23B$1.24B$1.19B$1.13B$1.15B$967.5M$845.3M$679.6M$554.3M$458.8M

Cash flow

Fiscal year FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Operating cash flow $127.3M$187.7M$181.1M$77.8M$231.8M$185.9M$145.0M$104.0M$24.8M$49.9M
Depreciation and amortisation $78.8M$82.2M$87.3M$86.9M$73.0M$61.1M$53.6M$51.4M$51.5M$58.4M
Stock-based compensation $44.5M$39.3M$55.3M$68.2M$53.2M$44.7M$34.0M$28.9M$21.9M$19.5M
Capital expenditure $40.4M$36.5M$41.5M$47.5M$29.0M$22.8M$15.9M$23.7M$15.3M$13.4M
Investing cash flow -$60.4M-$52.8M-$55.0M-$58.7M-$412.5M-$279.9M-$61.7M-$54.4M-$35.0M-$341.3M
Financing cash flow -$218.3M-$235.6M$23.4M-$21.0M$47.4M$456.3M-$23.5M-$13.6M-$9.9M$263.8M
Buybacks $77.6M$0$0$52.2M$0$53.0M$0$0$0$0

Figures as tagged in each year's own filing, in US dollars. A year restated by a later filing shows the restated figure. Capital expenditure, dividends and buybacks are cash out, shown positive. A line the filer does not report is not listed. Latest from accession 0001104659-26-042631.

Others in SIC 3571

TickerCompanyMarket capP/ERevenue growth
AAPL Apple Inc. $4.67T 42.9x 6.4%
DELL Dell Technologies Inc. $340.17B 60.4x 18.8%
SMCI Super Micro Computer, Inc. $26.01B 12.1x 77.8%
OSS ONE STOP SYSTEMS, INC. $248.7M 45.3x 31.2%
SCKT SOCKET MOBILE, INC. $5.1M -19.6%
ZEPP Zepp Health Corp 41.8%
XNDU Xanadu Quantum Technologies Ltd